Inhibition of platelet aggregation by adenosine receptor agonists (original) (raw)
Born R, Cross MJ (1963) The aggregation of blood platelets. J Physiol 168: 178–195 PubMedCAS Google Scholar
Brackett LE, Daly JW (1993) Characterization of the A2b adenosine (ADO) receptor in NIH 3T3 bibroblasts. FASEB J7:A 693 Google Scholar
Bruns RF (1980) Adenosine receptor activation in human fibroblasts. Nucleoside agonists and antagonists. Can J Physiol Pharmacal 58: 673–691 CAS Google Scholar
Bruns RF, Lu OH, Pugsley TA (1986) Charactenzation of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol. Pharmacal 29:331–346 CAS Google Scholar
Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant K1 and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacal 22:3099–3108 ArticleCAS Google Scholar
Cornfield LJ, Hu S, Hurt SD, Sills MA (1992) [3H]2-phenylaminoadenosine (3H]CV 1808) labels a novel adenosine receptor in rat brain. J Pharmacal Exp Ther 263:552–561 CAS Google Scholar
Cristalli G, Franchetti P, Orifantim M, Vittori S, Klotz K-N, Lohse MJ (1988) Adenosine receptor agonists: Synthesis and biological evaluation of l-deaza analogues of adenosine derivatIves. J Med Chem 31:1179–1183 ArticlePubMedCAS Google Scholar
Cristalli G. Eleuteri A. VIttori S, Volpini R, Lohse MJ. Klotz KN (1992) 2-Alkynyl derivatives of adenosine and N-ethyladenosine-5'-uronamide as selective agonists at A2 adenosine receptors. J Med Chem 35:2363–2368 ArticlePubMedCAS Google Scholar
Cusack NJ, Hourani SMO (1990) Subtypes of P2-purinoceptors: Studies using ATP analogues. Ann NY Acad Sci 603: 172–181 ArticlePubMedCAS Google Scholar
Daly JW, Padgett WL (1992) Agomst activity of 2- and 5'-substituted adenosine analogues and their N6-cycloalkyl derivatives at A1 - and A2-adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 43:1089–1093 ArticlePubMedCAS Google Scholar
Daly JW, Butts-Lamp P, Padgett W (1983) Subclasses of adenosine receptors rn the central nervous system: Interaction with caffeine and related methylxanthines. Cell Mol Neurobrol 3:69–80 ArticleCAS Google Scholar
Daly JW, Padgett WL, Secunda SI, Thompson RD, Olsson RA (1993) Structure-activity relationships for 2-substituted adenosines at A1 and A2 adenosine receptors. Pharmacology 46:91–100 ArticlePubMedCAS Google Scholar
Dionisotti S. Zocchi C, Varam K, Borea PA, Ongim E (1992) Effects of adenosrne derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn-Schmiedebergs Arch Pharmacol 346:673–676 PubMedCAS Google Scholar
Fleysher MH (1972) N6-substituted adenosines: Synthesis, biological activity, and some structure-activity relationships, J Med Chem 15:187–191 ArticlePubMedCAS Google Scholar
Hamilton HW, Taylor Md, Steffen RP, Haleen SJ, Brum RF (1987) Correlation of adenosrne receptor affinities and cardiovascular actIvity. Life Sci 41:2295–2302 ArticlePubMedCAS Google Scholar
Haslam RJ, Cusack NJ (1981) Blood Platelet receptors for ADP and for adenosine. In: G Burnstock (ed) Purinergic receptors. Chapman and Hall. New York, pp 223–285 Google Scholar
Haslam RJ, Rosson OM (1975) Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol Pharmacal 11:528–544 CAS Google Scholar
Hutchison KA, Nevins B, Perini F, Fox IJ (1990) Soluble and membrane-associated human low-affinity adenosine-binding protein (adenotin): Properties and homology with mammalian and avian stress proteins. Biochemistry 29:5138–5144 ArticlePubMedCAS Google Scholar
Kusachi S, Thompson RD, Olsson RA (1983) Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther 227:316–321 PubMedCAS Google Scholar
Lohse MJ, Elger B, Lindenborn-Fotinos J, Klotz K-N, Schwabe U (1988 a) Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtratron. Naunyn-Schmiedebergs Arch Pharmacal 337:64–68 CAS Google Scholar
Lohse MJ, Klotz KN, Schwabe U, Cristalli G, Vittori S, Orifantini M (1988 b) 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at AI adenosine receptors. Naunyn-Schmiedebergs Arch Pharmacal 337:687–689 CAS Google Scholar
Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554 ArticlePubMedCAS Google Scholar
Martin PL (1992) Relative agonist potencies of C2-substituted analogues of adenosine: eVIdence for adenosine A2b receptors in the guinea pig aorta. Eur J Pharmacal 216:235–242 ArticleCAS Google Scholar
Niiya K, Thompson RD, Silvia SK, Olsson RA (1992) 2-(N’-aralkylidenehydrazino) adenosines: Potent and selective coronary vasodilators. J Med Chem 35:4562–4566 ArticlePubMedCAS Google Scholar
Prasad RN, Bariana DS, Fung A, Savic M, Tietje K, Stein HH, Brondyk H, Egan RS (1980) Modification of the 5’ position of purine nucleosides. 2. Synthesis and cardiovascular propertIes of adenosine-5’-(N-substituted) carboxamides. J Med Chem 23:313319 Article Google Scholar
Robins MJ, Uznanski B (1981) Nucleic acid related compounds. 34. Non-aqueous diazotization with tert-butyl nitrite. Introduction of fluorine, chlorine and bromine at C-2 of purine nucleosides. Can J Chem 59:2608–2611 ArticleCAS Google Scholar
Snedecor OW, Cochran WO (1967) Statistical methods, 6th ed. Iowa State Umversity Press, Ames, Iowa Google Scholar
Stehle OH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD, Reppert SM (1992) Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol 6:384–393 ArticlePubMedCAS Google Scholar
Thompson RD, Secunda S, Daly JW, Olsson RA (1991) Activity of N6-substituted 2-chloroadenosrnes at A1 and A2 adenosine receptors. J Med Chem 34:3388–3390 ArticlePubMedCAS Google Scholar
Ueeda M, Thompson RD, Arroyo L, Olsson RA (1991 a) 2-Alkoxyadenosines: Potent and selective agomsts at the coronary artery A, adenosine receptor. J Med Chem 34: 1340–1344 ArticlePubMedCAS Google Scholar
Ueeda M, Thompson RD, Arroyo L, Olsson RA (1991 b) 2-Aralkoxyadenosines: Potent and selective agonists at the coronary artery A2 adenosine receptor. J Med Chem 34: 1340–1344 ArticlePubMedCAS Google Scholar
Ueeda M, Thompson RD, Padgett WL, Secunda S, Daly JW, Olsson RA (1991 c) Cardiovascular actions of adenosrnes, but not adenosine receptors, differ in rat and guinea pig. Life SCI 49: 1351–1358 ArticlePubMedCAS Google Scholar
Ukena D, Bohme E, Schwabe U (1984) Effects of severa15'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells. Naunyn-Schmiedebergs Arch Pharmacol 327:36–42 ArticlePubMedCAS Google Scholar
Ukena D, Olsson RA, Daly JW (1987) Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors. Can J Physiol Pharmacol 65:365–376 PubMedCAS Google Scholar
Van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via tv-o separate receptors, the accumulation of cyclic AMP in cultured bram cells. J Neurochem 33:999–1005 ArticlePubMed Google Scholar